Detalhe da pesquisa
1.
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma.
Eur Urol
; 80(2): 162-170, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33867192
2.
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer.
J Clin Oncol
; 39(21): 2359-2366, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961488